Literature DB >> 4730199

Changes in serum creatine phosphokinase during submaximal exercise testing.

J R Ledwich.   

Abstract

The changes in creatine phosphokinase with exercise were studied in 70 subjects who had a submaximal exercise electrocardiogram carried out as part of their routine medical investigation. A significantly greater proportion of the subjects with a positive exercise ECG had a rise in CPK following exercise than did the subjects with a negative exercise ECG. The former had significantly lower initial CPK values, and this difference could be related to the different alteration of CPK with exercise in the two groups, for example by indicating a lower level of physical fitness in the group with positive exercise ECGs. However, the most likely explanation for the greater tendency of subjects with a positive exercise ECG to show a rise in CPK following exercise is greater CPK efflux from their ischemic myocardium.With refinements, measurement of CPK before and after exercise could be useful in helping to evaluate the diagnostic significance of the exercise ECG.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4730199      PMCID: PMC1946839     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  20 in total

1.  Multiple-lead exercise electrocardiography. Experience in 107 normal subjects and 67 patients with angina pectoris, and comparison with coronary cinearteriography in 84 patients.

Authors:  R E Mason; I Likar; R O Biern; R S Ross
Journal:  Circulation       Date:  1967-10       Impact factor: 29.690

2.  An improved procedure for serum creatine phosphokinase determination.

Authors:  S B Rosalki
Journal:  J Lab Clin Med       Date:  1967-04

3.  Creatine kinase and glutamic oxalacetic transaminase activity in serum: kinetics of change with exercise and effect of physical conditioning.

Authors:  F Q Nuttall; B Jones
Journal:  J Lab Clin Med       Date:  1968-05

4.  The effect of exercise on serum enzymes.

Authors:  W M Fowler; G W Gardner; H H Kazerunian; W A Lauvstad
Journal:  Arch Phys Med Rehabil       Date:  1968-10       Impact factor: 3.966

5.  Serum enzyme changes following cardiac catheterizations with and without selective coronary arteriography.

Authors:  D D Michie; M A Conley; R F Carretta; R W Booth
Journal:  Am J Med Sci       Date:  1970-07       Impact factor: 2.378

6.  Effect of hypoxia and muscular activity on plasma enzyme levels in dogs.

Authors:  D J Loegering; J B Critz
Journal:  Am J Physiol       Date:  1971-01

7.  Determination and statistical analyses of the normal ranges for five serum enzymes.

Authors:  W H Thomson
Journal:  Clin Chim Acta       Date:  1968-09       Impact factor: 3.786

8.  Correlation between coronary arteriography and the postexercise electrocardiogram.

Authors:  M A Demany; A Tambe; H A Zimmerman
Journal:  Am J Cardiol       Date:  1967-04       Impact factor: 2.778

9.  Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity.

Authors:  P D Griffiths
Journal:  Clin Chim Acta       Date:  1966-04       Impact factor: 3.786

10.  Postexercise electrocardiogram in arteriosclerotic heart disease. Its value in diagnosis and prognosis.

Authors:  G P Robb; H H Marks
Journal:  JAMA       Date:  1967-06-12       Impact factor: 56.272

View more
  3 in total

1.  Effect of treadmill exercise testing on serum enzymes and the resting electrocardiogram.

Authors:  R G McAllister; L Weidner
Journal:  Can Med Assoc J       Date:  1975-06-07       Impact factor: 8.262

2.  [Study of the valuations of serum muscular enzymes and myoglobin after maximal exercise test and during the next 24 hours (author's transl)].

Authors:  C Besson; P Rochcongar; Y Beauverger; J Dassonville; M Aubrée; M Catheline
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1981

3.  Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.

Authors:  R F Gaines; S M Pueschel; E A Sassaman; J L Driscoll
Journal:  J Med Genet       Date:  1982-02       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.